Cart 0
BETA TRUTIDE -The Next-Gen Triagonist for Obesity, Diabetes & Liver Health
BETA TRUTIDE -The Next-Gen Triagonist for Obesity, Diabetes & Liver Health
BETA TRUTIDE -The Next-Gen Triagonist for Obesity, Diabetes & Liver Health
BETA TRUTIDE -The Next-Gen Triagonist for Obesity, Diabetes & Liver Health
BETA TRUTIDE -The Next-Gen Triagonist for Obesity, Diabetes & Liver Health
BETA TRUTIDE -The Next-Gen Triagonist for Obesity, Diabetes & Liver Health

BETA TRUTIDE -The Next-Gen Triagonist for Obesity, Diabetes & Liver Health

Tax included. Shipping calculated at checkout.

Free shipping on prepaid orders!

BETA TRUTIDE

RETATRUTIDE (Triple Agonist Injection)

The Next-Gen Triagonist for Obesity, Diabetes & Liver Health

Contents:
Retatrutide 5mg Vials (for SC/IM Administration) × 5
Sterile Water for Injection (2ml Ampoules) × 5

What is BETA TRUTIDE?

BETA TRUTIDE is an investigational, first-in-class triple hormone receptor agonist designed to tackle obesity, type 2 diabetes, and nonalcoholic steatohepatitis (NASH). Unlike existing GLP-1 or dual agonists, BETA TRUTIDE uniquely targets three complementary metabolic pathways for unmatched efficacy:

  • GLP-1 Receptor: Stimulates insulin secretion, reduces appetite, and delays gastric emptying.
  • GIP Receptor: Enhances insulin release and optimizes fat metabolism.
  • Glucagon Receptor: Elevates energy expenditure and promotes fat breakdown through thermogenesis.

This triagonist approach amplifies metabolic control, delivering superior weight loss, enhanced glycemic regulation, and marked reductions in liver fat.

 BETA TRUTIDE Front with Vial BETA TRUTIDE How it Helps

How BETA TRUTIDE Helps

1. Weight Management
Demonstrates robust weight loss (greater than dual agonists in early studies). Encourages visceral fat reduction and sustained BMI improvements. Boosts energy expenditure through glucagon-driven thermogenesis.

2. Diabetes Care
Improves fasting and postprandial glucose control. Achieves significant HbA1c reduction, even in resistant cases. Offers lower hypoglycemia risk due to glucose-dependent action.

3. Liver Health (NASH Benefits)
Reduces hepatic fat accumulation. Improves liver function markers. Potential therapeutic option for NASH patients with metabolic syndrome.

Administration & Storage

Route of Administration:
Subcutaneous (SC) or Intramuscular (IM) injection.

Storage Guidelines:

  • Before Reconstitution: Store at room temperature (≤25°C), protected from heat and sunlight.
  • After Reconstitution: Refrigerate at 2–8°C; use within the recommended time.
  • Do not freeze or expose to direct light.

Dosage Protocol

Recommended Titration Schedule:

  • Initial Dose: 2mg once weekly for 4 weeks.
  • Escalation: Increase to 4mg, 8mg, or up to 12mg weekly as tolerated.
  • Dose Increments: Every 4 weeks under medical supervision.

This gradual titration helps minimize GI side effects (nausea, vomiting) and ensures better compliance. All dose adjustments should be supervised by a healthcare professional.

For quality assurance, you can review the

Certificate of Analysis (COA)

 

 BETA TRUTIDE Dosage Comparison

Comparison: VITAGLUCIDE (Tirzepatide) vs. BETA TRUTIDE (Retatrutide)

VITAGLUCIDE (Tirzepatide) is a powerful dual-acting incretin therapy that combines GIP and GLP-1 receptor agonism. It has proven to be highly effective in managing type 2 diabetes and obesity, delivering significant weight loss, better glycemic control, and cardiovascular benefits. Its dual mechanism has made it a preferred option for patients seeking well-documented outcomes with a balance of efficacy and tolerability.

BETA TRUTIDE (Retatrutide), however, represents the next leap forward in incretin-based therapy. By targeting three receptors—GLP-1, GIP, and Glucagon—it provides broader and more powerful metabolic effects. In addition to superior weight loss and glucose regulation compared to dual agonists, BETA TRUTIDE also shows promising benefits in reducing liver fat, making it a potential breakthrough therapy for nonalcoholic steatohepatitis (NASH). This triple-action profile positions it as a more comprehensive solution for metabolic disease management.

In short, VITAGLUCIDE delivers excellent dual-action results for diabetes and obesity, while BETA TRUTIDE raises the bar with its triagonist approach, offering broader metabolic benefits that extend into liver health. The choice depends on whether a patient requires proven dual-agonist therapy or is ready for a next-generation treatment with wider potential advantages.

Contraindications

Avoid BETA TRUTIDE if:

  • Personal/family history of medullary thyroid carcinoma (MTC).
  • Diagnosis of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • Known hypersensitivity to retatrutide or formulation excipients.

Special Precautions

  1. Thyroid Tumors
    C-cell tumors observed in animal studies; human relevance is uncertain. Avoid use in high-risk individuals and monitor as advised by clinician.
  2. Pancreatitis
    Discontinue if severe or persistent abdominal pain occurs.
  3. Renal Impairment
    Use caution—GI side effects causing dehydration may worsen kidney function.
  4. Diabetic Retinopathy
    Rapid glycemic improvements can transiently worsen retinopathy—monitor closely.
  5. Pregnancy & Lactation
    Not recommended; safety not established.
 Precautions Packaging

Adverse Drug Reactions

Common: Nausea, diarrhea, vomiting, constipation, appetite suppression, abdominal discomfort.

Rare: Injection site reactions, hypersensitivity, dehydration, gallbladder dysfunction, thyroid changes, visual disturbances.

Drug Interactions

  • Insulin or Sulfonylureas: Increased risk of hypoglycemia — dose adjustments and monitoring required.
  • Oral Medications: Delayed gastric emptying may affect absorption — review concomitant medications.

Why Choose BETA TRUTIDE?

✅ Triple hormone receptor agonist (GLP-1 + GIP + Glucagon).
✅ Superior weight loss, glucose control, and liver fat reduction.
✅ Potential breakthrough therapy for diabetes + obesity + NASH.
✅ Flexible titration for tailored metabolic impact.

Disclaimer

  • Product images are representational; actual packaging may vary.
  • For investigational/medical use under healthcare supervision only — not for self-administration without a clinician's guidance.
  • Store as directed to preserve efficacy.

FAQs

Q1. What is BETA TRUTIDE (Retatrutide)?
BETA TRUTIDE is a first-in-class triple hormone receptor agonist that targets GLP-1, GIP, and Glucagon receptors. It is being investigated for the treatment of obesity, type 2 diabetes, and nonalcoholic steatohepatitis (NASH).

Q2. How does BETA TRUTIDE work?
It works by activating three complementary metabolic pathways: GLP-1 for appetite suppression and insulin secretion, GIP for enhanced insulin release and fat metabolism, and Glucagon for increased energy expenditure and thermogenesis.

Q3. What are the key benefits of BETA TRUTIDE?
BETA TRUTIDE offers superior weight loss compared to dual agonists, improved glycemic control (HbA1c reduction), and significant reduction in liver fat, making it a potential breakthrough for NASH patients.

Q4. What is the recommended dosage?
The recommended titration schedule is: start at 2mg once weekly for 4 weeks, then increase to 4mg, 8mg, or up to 12mg weekly as tolerated, with dose increments every 4 weeks under medical supervision.

Q5. How is BETA TRUTIDE administered?
It is administered via subcutaneous (SC) or intramuscular (IM) injection.

Q6. How should BETA TRUTIDE be stored?
Before reconstitution, store at room temperature (≤25°C), protected from heat and sunlight. After reconstitution, refrigerate at 2–8°C and use within the recommended time. Do not freeze or expose to direct light.

Q7. What are the common side effects?
Common side effects include nausea, diarrhea, vomiting, constipation, appetite suppression, and abdominal discomfort. These are typically mild to moderate and diminish over time.

Q8. Who should avoid BETA TRUTIDE?
BETA TRUTIDE should be avoided by individuals with a personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or known hypersensitivity to retatrutide or any of its excipients.

Q9. Can BETA TRUTIDE be used with other medications?
Caution is advised when used with insulin or sulfonylureas due to increased risk of hypoglycemia. Dose adjustments and monitoring may be required. Delayed gastric emptying may affect the absorption of oral medications.

Q10. Is BETA TRUTIDE better than VITAGLUCIDE (Tirzepatide)?
While VITAGLUCIDE is a highly effective dual agonist, BETA TRUTIDE offers a broader metabolic profile with its triple agonist approach, potentially providing superior weight loss, glucose control, and additional liver health benefits. The choice depends on individual patient needs and clinical goals.

Important Update: Mandatory ₹260 Pre-payment for COD Orders to Ensure Authenticity and Reduce Fraud.

For more information, Please feel free to contact us via Call/WhatsApp at:

Order and Delivery 

  • +91 84 48 595260 in Hindi / English.

Dosage and Cycle Suggestion

  • +91 98 71 517328 in English.
  • +91 99 71 989387 in Hindi.

Working Hours: Everyday 9 AM to 10 PM.

________________________________________

महत्वपूर्ण सुचना : ऑर्डर्स की ऑथेंटिसिटी और जेनुइन कस्टमर्स की वेरिफिकेशन के लिए ₹260 कैश ऑन डिलीवरी चार्जेस का प्री-पेमेंट आवश्यक है।

और अधिक जानकारी के लिए आप हमें कॉल/व्हाट्सएप्प द्वारा संपर्क कर सकते हैं :


आर्डर और डिलीवरी

+91 84 48 595260 in हिंदी / इंग्लिश.

डोसेज और साइकल सजेशन :

+91 98 71 517328 इंग्लिश .
+91 99 71 989387 हिंदी.

वर्किंग टाइम : प्रतिदिन 10 AM से 10 PM तक .

________________________________

முக்கிய அறிவிப்பு: ஆர்டர்களின் அசல்தன்மை மற்றும் உண்மையான வாடிக்கையாளர்களின் சரிபார்ப்புக்காக ₹260 கேஷ் ஆன் டெலிவரி கட்டணத்தின் முன்பணம் கட்டுவது அவசியம்.

மேலும் தகவல்களுக்கு நீங்கள் கால்/வாட்ஸ்அப் மூலம் எங்களை தொடர்பு கொள்ளலாம்:

ஆர்டர் மற்றும் டெலிவரி

+91 84 48 595260 தமிழ் / ஆங்கிலம்.

டோசேஜ் மற்றும் சைக்கிள் ஆலோசனைகள்:

+91 98 71 517328 ஆங்கிலம். +91 99 71 989387 தமிழ்.

வேலை நேரம்: தினசரி 10 AM முதல் 10 PM வரை.

See what our Customers have to say 

We Also Recommend

VITAGLUCIDE (Tirzepatide Injection) - The Dual-Action Powerhouse for Diabetes and Weight Management

VITAGLUCIDE (Tirzepatide Injection) - The Dual-Action Powerhouse for Diabetes and Weight Management
denik Glycotide(Semaglutide Injection): The Innovative Most efficient f͏at loss Peptide ever created.

denik Glycotide(Semaglutide Injection): The Innovative Most efficient f͏at loss Peptide ever created.
Bestseller
FRAG-RIP ( hGH Fragment): Power of Human Growth Hormone for Extreme and safe Fat loss

FRAG-RIP ( hGH Fragment): Power of Human Growth Hormone for Extreme and safe Fat loss
Bestseller
OTOTROPIN: Truest rDNA Somatropin (hGH) for Muscle Growth, fat Loss, Performance and Anti Ageing.

OTOTROPIN: Truest rDNA Somatropin (hGH) for Muscle Growth, fat Loss, Performance and Anti Ageing.
GROSIX-DS(GHRP-6): Powerful GHRH for Growth, Performance, recovery and Anti ageing. GRHELIN for bigger Diet and Massive Bulk.

GROSIX-DS(GHRP-6): Powerful GHRH for Growth, Performance, recovery and Anti ageing. GRHELIN for bigger Diet and Massive Bulk.
Description

BETA TRUTIDE

RETATRUTIDE (Triple Agonist Injection)

The Next-Gen Triagonist for Obesity, Diabetes & Liver Health

Contents:
Retatrutide 5mg Vials (for SC/IM Administration) × 5
Sterile Water for Injection (2ml Ampoules) × 5

What is BETA TRUTIDE?

BETA TRUTIDE is an investigational, first-in-class triple hormone receptor agonist designed to tackle obesity, type 2 diabetes, and nonalcoholic steatohepatitis (NASH). Unlike existing GLP-1 or dual agonists, BETA TRUTIDE uniquely targets three complementary metabolic pathways for unmatched efficacy:

  • GLP-1 Receptor: Stimulates insulin secretion, reduces appetite, and delays gastric emptying.
  • GIP Receptor: Enhances insulin release and optimizes fat metabolism.
  • Glucagon Receptor: Elevates energy expenditure and promotes fat breakdown through thermogenesis.

This triagonist approach amplifies metabolic control, delivering superior weight loss, enhanced glycemic regulation, and marked reductions in liver fat.

 BETA TRUTIDE Front with Vial BETA TRUTIDE How it Helps

How BETA TRUTIDE Helps

1. Weight Management
Demonstrates robust weight loss (greater than dual agonists in early studies). Encourages visceral fat reduction and sustained BMI improvements. Boosts energy expenditure through glucagon-driven thermogenesis.

2. Diabetes Care
Improves fasting and postprandial glucose control. Achieves significant HbA1c reduction, even in resistant cases. Offers lower hypoglycemia risk due to glucose-dependent action.

3. Liver Health (NASH Benefits)
Reduces hepatic fat accumulation. Improves liver function markers. Potential therapeutic option for NASH patients with metabolic syndrome.

Administration & Storage

Route of Administration:
Subcutaneous (SC) or Intramuscular (IM) injection.

Storage Guidelines:

  • Before Reconstitution: Store at room temperature (≤25°C), protected from heat and sunlight.
  • After Reconstitution: Refrigerate at 2–8°C; use within the recommended time.
  • Do not freeze or expose to direct light.

Dosage Protocol

Recommended Titration Schedule:

  • Initial Dose: 2mg once weekly for 4 weeks.
  • Escalation: Increase to 4mg, 8mg, or up to 12mg weekly as tolerated.
  • Dose Increments: Every 4 weeks under medical supervision.

This gradual titration helps minimize GI side effects (nausea, vomiting) and ensures better compliance. All dose adjustments should be supervised by a healthcare professional.

For quality assurance, you can review the

Certificate of Analysis (COA)

 

 BETA TRUTIDE Dosage Comparison

Comparison: VITAGLUCIDE (Tirzepatide) vs. BETA TRUTIDE (Retatrutide)

VITAGLUCIDE (Tirzepatide) is a powerful dual-acting incretin therapy that combines GIP and GLP-1 receptor agonism. It has proven to be highly effective in managing type 2 diabetes and obesity, delivering significant weight loss, better glycemic control, and cardiovascular benefits. Its dual mechanism has made it a preferred option for patients seeking well-documented outcomes with a balance of efficacy and tolerability.

BETA TRUTIDE (Retatrutide), however, represents the next leap forward in incretin-based therapy. By targeting three receptors—GLP-1, GIP, and Glucagon—it provides broader and more powerful metabolic effects. In addition to superior weight loss and glucose regulation compared to dual agonists, BETA TRUTIDE also shows promising benefits in reducing liver fat, making it a potential breakthrough therapy for nonalcoholic steatohepatitis (NASH). This triple-action profile positions it as a more comprehensive solution for metabolic disease management.

In short, VITAGLUCIDE delivers excellent dual-action results for diabetes and obesity, while BETA TRUTIDE raises the bar with its triagonist approach, offering broader metabolic benefits that extend into liver health. The choice depends on whether a patient requires proven dual-agonist therapy or is ready for a next-generation treatment with wider potential advantages.

Contraindications

Avoid BETA TRUTIDE if:

  • Personal/family history of medullary thyroid carcinoma (MTC).
  • Diagnosis of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
  • Known hypersensitivity to retatrutide or formulation excipients.

Special Precautions

  1. Thyroid Tumors
    C-cell tumors observed in animal studies; human relevance is uncertain. Avoid use in high-risk individuals and monitor as advised by clinician.
  2. Pancreatitis
    Discontinue if severe or persistent abdominal pain occurs.
  3. Renal Impairment
    Use caution—GI side effects causing dehydration may worsen kidney function.
  4. Diabetic Retinopathy
    Rapid glycemic improvements can transiently worsen retinopathy—monitor closely.
  5. Pregnancy & Lactation
    Not recommended; safety not established.
 Precautions Packaging

Adverse Drug Reactions

Common: Nausea, diarrhea, vomiting, constipation, appetite suppression, abdominal discomfort.

Rare: Injection site reactions, hypersensitivity, dehydration, gallbladder dysfunction, thyroid changes, visual disturbances.

Drug Interactions

  • Insulin or Sulfonylureas: Increased risk of hypoglycemia — dose adjustments and monitoring required.
  • Oral Medications: Delayed gastric emptying may affect absorption — review concomitant medications.

Why Choose BETA TRUTIDE?

✅ Triple hormone receptor agonist (GLP-1 + GIP + Glucagon).
✅ Superior weight loss, glucose control, and liver fat reduction.
✅ Potential breakthrough therapy for diabetes + obesity + NASH.
✅ Flexible titration for tailored metabolic impact.

Disclaimer

  • Product images are representational; actual packaging may vary.
  • For investigational/medical use under healthcare supervision only — not for self-administration without a clinician's guidance.
  • Store as directed to preserve efficacy.

FAQs

Q1. What is BETA TRUTIDE (Retatrutide)?
BETA TRUTIDE is a first-in-class triple hormone receptor agonist that targets GLP-1, GIP, and Glucagon receptors. It is being investigated for the treatment of obesity, type 2 diabetes, and nonalcoholic steatohepatitis (NASH).

Q2. How does BETA TRUTIDE work?
It works by activating three complementary metabolic pathways: GLP-1 for appetite suppression and insulin secretion, GIP for enhanced insulin release and fat metabolism, and Glucagon for increased energy expenditure and thermogenesis.

Q3. What are the key benefits of BETA TRUTIDE?
BETA TRUTIDE offers superior weight loss compared to dual agonists, improved glycemic control (HbA1c reduction), and significant reduction in liver fat, making it a potential breakthrough for NASH patients.

Q4. What is the recommended dosage?
The recommended titration schedule is: start at 2mg once weekly for 4 weeks, then increase to 4mg, 8mg, or up to 12mg weekly as tolerated, with dose increments every 4 weeks under medical supervision.

Q5. How is BETA TRUTIDE administered?
It is administered via subcutaneous (SC) or intramuscular (IM) injection.

Q6. How should BETA TRUTIDE be stored?
Before reconstitution, store at room temperature (≤25°C), protected from heat and sunlight. After reconstitution, refrigerate at 2–8°C and use within the recommended time. Do not freeze or expose to direct light.

Q7. What are the common side effects?
Common side effects include nausea, diarrhea, vomiting, constipation, appetite suppression, and abdominal discomfort. These are typically mild to moderate and diminish over time.

Q8. Who should avoid BETA TRUTIDE?
BETA TRUTIDE should be avoided by individuals with a personal or family history of medullary thyroid carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or known hypersensitivity to retatrutide or any of its excipients.

Q9. Can BETA TRUTIDE be used with other medications?
Caution is advised when used with insulin or sulfonylureas due to increased risk of hypoglycemia. Dose adjustments and monitoring may be required. Delayed gastric emptying may affect the absorption of oral medications.

Q10. Is BETA TRUTIDE better than VITAGLUCIDE (Tirzepatide)?
While VITAGLUCIDE is a highly effective dual agonist, BETA TRUTIDE offers a broader metabolic profile with its triple agonist approach, potentially providing superior weight loss, glucose control, and additional liver health benefits. The choice depends on individual patient needs and clinical goals.
Cash On delivery Orders

Important Update: Mandatory ₹260 Pre-payment for COD Orders to Ensure Authenticity and Reduce Fraud.

For more information, Please feel free to contact us via Call/WhatsApp at:

Order and Delivery 

  • +91 84 48 595260 in Hindi / English.

Dosage and Cycle Suggestion

  • +91 98 71 517328 in English.
  • +91 99 71 989387 in Hindi.

Working Hours: Everyday 9 AM to 10 PM.

________________________________________

महत्वपूर्ण सुचना : ऑर्डर्स की ऑथेंटिसिटी और जेनुइन कस्टमर्स की वेरिफिकेशन के लिए ₹260 कैश ऑन डिलीवरी चार्जेस का प्री-पेमेंट आवश्यक है।

और अधिक जानकारी के लिए आप हमें कॉल/व्हाट्सएप्प द्वारा संपर्क कर सकते हैं :


आर्डर और डिलीवरी

+91 84 48 595260 in हिंदी / इंग्लिश.

डोसेज और साइकल सजेशन :

+91 98 71 517328 इंग्लिश .
+91 99 71 989387 हिंदी.

वर्किंग टाइम : प्रतिदिन 10 AM से 10 PM तक .

________________________________

முக்கிய அறிவிப்பு: ஆர்டர்களின் அசல்தன்மை மற்றும் உண்மையான வாடிக்கையாளர்களின் சரிபார்ப்புக்காக ₹260 கேஷ் ஆன் டெலிவரி கட்டணத்தின் முன்பணம் கட்டுவது அவசியம்.

மேலும் தகவல்களுக்கு நீங்கள் கால்/வாட்ஸ்அப் மூலம் எங்களை தொடர்பு கொள்ளலாம்:

ஆர்டர் மற்றும் டெலிவரி

+91 84 48 595260 தமிழ் / ஆங்கிலம்.

டோசேஜ் மற்றும் சைக்கிள் ஆலோசனைகள்:

+91 98 71 517328 ஆங்கிலம். +91 99 71 989387 தமிழ்.

வேலை நேரம்: தினசரி 10 AM முதல் 10 PM வரை.

Reviews

See what our Customers have to say